These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19857765)

  • 21. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN; Chick J; Good AM; Kelly CA; Masterton G
    Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of serotonin syndrome caused by venlafaxine and lithium.
    Mekler G; Woggon B
    Pharmacopsychiatry; 1997 Nov; 30(6):272-3. PubMed ID: 9442552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
    Shamseddeen W; Clarke G; Keller MB; Wagner KD; Birmaher B; Emslie GJ; Ryan N; Asarnow JR; Porta G; Brent DA
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):29-36. PubMed ID: 22251024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
    de Abajo FJ; García-Rodríguez LA
    Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.
    Kirby D; Harrigan S; Ames D
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):231-7. PubMed ID: 11921151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy.
    Idilman R; Ersoz S; Coban S; Kumbasar O; Bozkaya H
    Liver Transpl; 2006 Sep; 12(9):1427-30. PubMed ID: 16933231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venlafaxine induced acute myocardial infarction with normal coronary arteries.
    Godkar D; Stensby J; Sinnapunayagam S; Niranjan S
    Am J Ther; 2009; 16(4):365-6. PubMed ID: 19617721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder].
    Tak LM; Stevens AW
    Tijdschr Psychiatr; 2013; 55(10):795-800. PubMed ID: 24166339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant options: venlafaxine in perspective.
    Thase ME
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venlafaxine and severe tinnitus.
    Ahmad S
    Am Fam Physician; 1995 Jun; 51(8):1830. PubMed ID: 7762476
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
    Hanekamp BB; Zijlstra JG; Tulleken JE; Ligtenberg JJ; van der Werf TS; Hofstra LS
    Neth J Med; 2005 Sep; 63(8):316-8. PubMed ID: 16186642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An organic psychosis due to a venlafaxine-propafenone interaction.
    Pfeffer F; Grube M
    Int J Psychiatry Med; 2001; 31(4):427-32. PubMed ID: 11949740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
    Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible venlafaxine-induced mania.
    Stoner SC; Williams RJ; Worrel J; Ramlatchman L
    J Clin Psychopharmacol; 1999 Apr; 19(2):184-5. PubMed ID: 10211922
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine.
    Prior FH; Isbister GK; Dawson AH; Whyte IM
    Med J Aust; 2002 Mar; 176(5):240-1. PubMed ID: 11999244
    [No Abstract]   [Full Text] [Related]  

  • 40. Fulminant chemical hepatitis possibly associated with donepezil and sertraline therapy.
    Verrico MM; Nace DA; Towers AL
    J Am Geriatr Soc; 2000 Dec; 48(12):1659-63. PubMed ID: 11129758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.